EFX vs INKT · P/E 54, rev $3.35B vs $59.1M cap
Equifax Inc (EFX) versus Mink Therapeutics Inc (INKT) — a side-by-side from cached financials, not a winner call.
Equifax Inc (EFX) is a consulting services company listed on US.
Mink Therapeutics Inc (INKT) is a biotechnology company listed on US.
Latest reported EFX revenue for 2026-06-30 was $3.35B. Net income was $355.4M. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
INKT does not have a complete income-statement cache yet.
EFX currently screens at market cap $33.00B and trailing P/E 54.0. INKT currently screens at market cap $59.1M.
Not investment advice. Open the EFX and INKT stock pages for the full models.
Not investment advice.